$Jazz Pharmaceuticals (JAZZ.US)$ JAZZ shares rose to 120-day...

$Jazz Pharmaceuticals (JAZZ.US)$ JAZZ shares rose to 120-day average pressure level in the early days on a large number of selling pressure, resulting in shares continued to be sold, coupled with the back of the company's latest results are not as good as the market expects, the stock was sold again, resulting in the stock into a very dangerous downtrend, and consecutively fell below a number of key support, the stock price in recent trading days, although the decline in the rebound, but the general market trend is relatively weak, coupled with the stock price of the technical The face has been broken, the risk of continuing to fall is very high, so it is recommended to take advantage of today's rebound to sell in time to leave the field, to avoid greater losses later.